Chief Medical Officer Dan Karlin said the company’s recent Phase III results for DT120 showed statistically significant improvements in generalized anxiety disorder, or GAD, and major depressive ...

Definium Therapeutics (NASDAQ:DFTX) reported positive top-line results from Panorama, its second Phase III study of DT120 ODT ...

Vor Biopharma Inc. is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a dual-ta ...

The "effort" shaken by generative AI and the value of artIn the previous article, I discussed how humans may be looking not just at the work itself, but also at who created it and through what kind of ...

There are plenty of ways for a more optimistic forecast to reach $80 or $100. Azetukalner could exceed $3 billion in epilepsy ...

Good morning, and welcome to the Kyverna Therapeutics Conference Call. [Operator Instructions] Please note, this call is being recorded. I would now like to introduce Jessica Serra, Head of Investor ...

In UI (User Interface) design, the idea that dark mode—where the background is darkened and text and information are displayed brightly—is simply 'cooler because it's darker' is generally not a ...

The Stockholm stock market was trading slightly lower around midday on Friday. The market is thus taking a breather after two ...

A simple blood draw that reads chemical tags on DNA shed by tumors has delivered a strikingly better performance than the ...

Detailed price information for Celldex Therapeutics (CLDX-Q) from The Globe and Mail including charting and trades.

A pungent condiment that has sat on Southeast Asian tables for centuries is now at the center of an unusual neuroscience ...

The White House has labeled critics terrorists, attributed violence to a left-wing conspiracy and investigated unions, nonprofits and other groups in a battle over free speech.